Skip to main content
Thomas Newton, MD, Psychiatry, Grand Junction, CO, SCL Health - St. Mary's Hospital and Medical Center

ThomasFrederickNewtonMD

Psychiatry • Grand Junction, CO

Professor, Psychiatry, Baylor Coll of Med

Join to view full profile

Dr. Newton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Newton's full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1985 - 1989
  • Yale School of Medicine
    Yale School of MedicineClass of 1985

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2017 - 2025
  • NY State Medical License
    NY State Medical License 2022 - 2024
  • MO State Medical License
    MO State Medical License 2021 - 2024
  • TX State Medical License
    TX State Medical License 2010 - 2024
  • CA State Medical License
    CA State Medical License 1987 - 2019
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Archival Report in Cocaine Dependence, Neural Prediction Errors During Loss Avoidance Are Increased with Cocaine Deprivation and Predict Drug Use  
    Thomas Newton, MD, ScienceDirect

Press Mentions

  • “Life-Threatening” Errors at Mental Health Center Went Undisclosed to Patients, Public
    “Life-Threatening” Errors at Mental Health Center Went Undisclosed to Patients, PublicMarch 20th, 2022
  • First Human Tests of Antidepressant Bupropion as Methamphetamine Addiction Treatment Hold Promise
    First Human Tests of Antidepressant Bupropion as Methamphetamine Addiction Treatment Hold PromiseNovember 29th, 2005
  • Therapists Question Canada's Action on Hyperactivity Drug
    Therapists Question Canada's Action on Hyperactivity DrugFebruary 12th, 2005

Grant Support

  • Clinical Research Education For Drug Abuse ProfessionalsNational Institute On Drug Abuse2011–2012
  • The Effects Of Doxazosin On The Cardiovascular And Subjective Effects Of CocaineNational Center For Research Resources2011
  • N-Acetylcysteine As A Potential Treatment For Methamphetamine DependenceNational Center For Research Resources2011
  • An ACE Inhibitor As A Treatment For Methamphetamine DependenceNational Center For Research Resources2010–2011
  • Human Laboratory StudiesNational Institute On Drug Abuse2009–2011
  • An ACE Inhibitor As A Treatment For Methamphetamine DependenceNational Institute On Drug Abuse2008–2011
  • Laboratory Models Of Cocaine Self AdministrationNational Center For Research Resources2010
  • N-Acetylcysteine As A Potential Treatment For Methamphetamine DependenceNational Institute On Drug Abuse2009–2010
  • Assess Of Stress Effects In Methamphetamine DependenceNational Institute On Drug Abuse2009–2010
  • Inhibitory Control And MA Self-Administration Modafinil EffectsNational Institute On Drug Abuse2008–2009
  • Trials Of Medications For Stimulant Abuse Research PLANNational Institute On Drug Abuse2004–2009
  • Laboratory Models Of Cocaine Self-AdministrationNational Institute On Drug Abuse2008
  • Modafinil As A Treatment For Methamphetamine Dependence: Initial Safety, SubjNational Center For Research Resources2008
  • Methamphetamine Dependence: A Novel Laboratory ModelNational Center For Research Resources2008
  • Effects Of Chronic Methamphetamine Use On SleepNational Center For Research Resources2008
  • Laboratory Models Of Cocaine Self AdministrationNational Center For Research Resources2007–2008
  • Assessment Of GVG For The Treatment Of Methamphetamine DependenceNational Center For Research Resources2007–2008
  • Pharmacological Manipulation Of Psychosocial StressNational Center For Research Resources2006–2008
  • Inhibitory Control And MA Self-Administration: Modafinil EffectsNational Institute On Drug Abuse2007
  • Cycloserine Enhancement Of Extinction LearningNational Institute On Drug Abuse2007
  • Nida-1 P50 DA 018185: Double-Blind, Randomized, Placebo-Controlled Trial Of RNational Center For Research Resources2006–2007
  • Laboratory Models Of Cocaine Self-AdministrationNational Institute On Drug Abuse2005–2007
  • Assess Of Stress Effects In Methamphetamine DependenceNational Institute On Drug Abuse2005–2007
  • Phase I, Double-Blind, Placebo-Controlled AssessmenNational Center For Research Resources2005–2007
  • Perindopril - Methamphetamine Interaction StudyNational Center For Research Resources2005–2007
  • Neuropsychological And Affective Sequelae Of 5-HT Depletion In MDMA UsersNational Center For Research Resources2005–2007
  • Inhibitory Control And MA Self-Administration: Modafinil EffectsNational Institute On Drug Abuse2006
  • Double-Blind, Placebo-Controlled Assessment Of Potential Interactions BetweenNational Center For Research Resources2005–2006
  • Perindopril-Methamphetamine Interaction StudyNational Institute On Drug Abuse2003–2006
  • Clinical Research Education For Drug Abuse ProfessionalsNational Institute On Drug Abuse2002–2006
  • Study Of The Relationships Among Serotonin, NeuropsychNational Center For Research Resources2004
  • Safety Assessment Of Interaction Btwn Cocaine And AmantaNational Center For Research Resources2004
  • Double-Blind, Placebo Controlled Assessment Of Potential Interactions Between...National Center For Research Resources2004
  • Assessment Of Potential Interactions Between Intravenous Methamphetamine And...National Center For Research Resources2004
  • Brain Changes In Drug Dependence--Clinical ImplicationsNational Institute On Drug Abuse1999–2003
  • Postdoctoral Interdisciplinary HIV-AIDSNational Institute Of Mental Health1999–2003
  • Safety Evaluation Of Cocaine Lisuride InteractionNational Center For Research Resources1999–2001
  • Challenge Study For Anti-Cocaine AntibodiesNational Institute On Drug Abuse1998–2001
  • Clinical Trial OperationsNational Institute On Drug Abuse2000

Hospital Affiliations

Dr. Thomas Newton, Dr. Thomas Newton, MD, Dr. T Newton, Dr. Thomas Frederick Newton